<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Pacific Biosciences Of California — News on 6ix</title>
<link>https://6ix.com/company/pacific-biosciences-of-california</link>
<description>Latest news and press releases for Pacific Biosciences Of California on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/pacific-biosciences-of-california" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835a7d878dffbe2df10c1ea.webp</url>
<title>Pacific Biosciences Of California</title>
<link>https://6ix.com/company/pacific-biosciences-of-california</link>
</image>
<item>
<title>PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-and-lucid-genomics-announce-compatibility-collaboration-to-advance-tertiary-analysis-for-long-read-sequencing</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-and-lucid-genomics-announce-compatibility-collaboration-to-advance-tertiary-analysis-for-long-read-sequencing</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>Expands access to streamlined genomic data analysis across the PacBio partner ecosystem MENLO PARK, Calif. & BERLIN, April 21, 2026 (GLOBE NEWSWIRE) -- PacBio</description>
</item>
<item>
<title>PacBio to Report First Quarter 2026 Financial Results on May 7, 2026</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-to-report-first-quarter-2026-financial-results-on-may-7-2026</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-to-report-first-quarter-2026-financial-results-on-may-7-2026</guid>
<pubDate>Thu, 16 Apr 2026 04:00:00 GMT</pubDate>
<description>MENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its</description>
</item>
<item>
<title>PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-and-covaris-announce-joint-workflow-enabling-hifi-long-read-sequencing-of-ffpe-tumor-samples</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-and-covaris-announce-joint-workflow-enabling-hifi-long-read-sequencing-of-ffpe-tumor-samples</guid>
<pubDate>Wed, 15 Apr 2026 04:00:00 GMT</pubDate>
<description>New extraction-to-library prep workflow enables highly accurate long-read sequencing from archived clinical samples, expanding opportunities in cancer</description>
</item>
<item>
<title>Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/basecamp-research-selects-pacbio-hifi-sequencing-to-power-trillion-gene-atlas-initiative</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/basecamp-research-selects-pacbio-hifi-sequencing-to-power-trillion-gene-atlas-initiative</guid>
<pubDate>Wed, 18 Mar 2026 04:00:00 GMT</pubDate>
<description>PacBio’s Revio system and SPRQ-Nx chemistry to enable an order-of-magnitude expansion of HiFi metagenomic sequencing for scaling AI-designed therapeutics</description>
</item>
<item>
<title>PacBio Announces the Appointment of Chris Gibson to the Board of Directors</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-announces-the-appointment-of-chris-gibson-to-the-board-of-directors-33</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-announces-the-appointment-of-chris-gibson-to-the-board-of-directors-33</guid>
<pubDate>Thu, 05 Mar 2026 05:00:00 GMT</pubDate>
<description>Proven experience in leveraging AI in biology will strengthen the board of directors as PacBio develops data tools to maximize the power of HiFi sequencing</description>
</item>
<item>
<title>PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-and-dnastack-launch-first-global-federated-hifi-whole-genome-dataset-to-accelerate-rare-disease-research</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-and-dnastack-launch-first-global-federated-hifi-whole-genome-dataset-to-accelerate-rare-disease-research</guid>
<pubDate>Tue, 24 Feb 2026 14:05:00 GMT</pubDate>
<description>Collaboration powers secure international data sharing through the HiFi Solves Global ConsortiumMENLO PARK, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced a collaboration with DNAstack to power the world’s first global federated dataset of HiFi whole genome sequencing data. Through the HiFi Solves Global Consortium, the collaboration enables secure international research — allowing genomic insights</description>
</item>
<item>
<title>PacBio to Participate in the TD Cowen 46th Annual Health Care Conference</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-to-participate-in-the-td-cowen-46th-annual-health-care-conference</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-to-participate-in-the-td-cowen-46th-annual-health-care-conference</guid>
<pubDate>Wed, 18 Feb 2026 21:05:00 GMT</pubDate>
<description>MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at TD Cowen's 46th Annual Health Care Conference on Monday, March 2, 2026, at 2:30 PM ET in Boston, MA. A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days f</description>
</item>
<item>
<title>PacBio to Participate in the TD Cowen 46th Annual Health Care Conference </title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-to-participate-in-the-td-cowen-46th-annual-health-care-conference-1</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-to-participate-in-the-td-cowen-46th-annual-health-care-conference-1</guid>
<pubDate>Wed, 18 Feb 2026 05:00:00 GMT</pubDate>
<description>MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,</description>
</item>
<item>
<title>PacBio Announces Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-announces-fourth-quarter-full-210500798</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-announces-fourth-quarter-full-210500798</guid>
<pubDate>Thu, 12 Feb 2026 21:05:00 GMT</pubDate>
<description>MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year results: Q4 2025Q4 2024FY 2025FY 2024Revenue (in millions)$44.6$39.2$160.0$154.0Consumable revenue (in millions)$21.6$18.8$82.0$70.3Instrument revenue (in millions)$17.3$15.3$53.8$65.8Service and other revenue (in millions)$5.7$5.1$24.2$17.9RevioTM system placements21236197VegaTM system placements427140</description>
</item>
<item>
<title>PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-joins-ihope-initiative-first-120000078</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-joins-ihope-initiative-first-120000078</guid>
<pubDate>Thu, 12 Feb 2026 12:00:00 GMT</pubDate>
<description>Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease NetworkMENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global rare disease genomics program of Genetic Alliance, to integrate PacBio’s HiFi® long-read whole-genome sequencing into iHope’s international network. iHope operates the wor</description>
</item>
<item>
<title>PacBio Completes Sale of Short-Read Sequencing Assets</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-completes-sale-short-read-140500371</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-completes-sale-short-read-140500371</guid>
<pubDate>Mon, 02 Feb 2026 14:05:00 GMT</pubDate>
<description>MENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select intellectual property and other assets related to PacBio’s short-read DNA sequencing technology and related clustering, sequencing reagent, and detection technologies to Illumina, Inc. PacBio received $48.1 million in net cash proceeds from the transaction. Under the terms of the agreement, Ill</description>
</item>
<item>
<title>PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-report-fourth-quarter-full-210500157</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-report-fourth-quarter-full-210500157</guid>
<pubDate>Tue, 27 Jan 2026 21:05:00 GMT</pubDate>
<description>MENLO PARK, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, at 5:00 pm Eastern Time. The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/. Date: Thursday, February 12, 2026, at 5:00 pm ET (2:00 pm PT) Listen live via internet or replay: https://investor.pacificbios</description>
</item>
<item>
<title>PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-announces-preliminary-fourth-quarter-140500863</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-announces-preliminary-fourth-quarter-140500863</guid>
<pubDate>Mon, 12 Jan 2026 14:05:00 GMT</pubDate>
<description>Q4 2025 revenue growth of 14% year-over-year, driven by strong Revio and Vega shipments and record consumables revenueMENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for the fourth quarter of 2025 and full year 2025 of $44.6 million and $160.0 million representing year-over-year growth of 14% and 4%, respectively. “We finished the year with strong moment</description>
</item>
<item>
<title>PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-hifi-adopted-first-line-140500363</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-hifi-adopted-first-line-140500363</guid>
<pubDate>Mon, 12 Jan 2026 14:05:00 GMT</pubDate>
<description>Trios from 200 families who have lost a child to SUDC to be sequenced on PacBio’s Revio system with SPRQ-Nx chemistry, enabling increased diagnostic yield for grieving familiesMENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced that a UW Medicine and Seattle Children’s research effort led by Danny Miller, MD, PhD, and Alexandra Keefe, MD, PhD, will employ PacBio HiFi whole-genome sequencing a</description>
</item>
<item>
<title>PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-announces-plans-collaboration-n-lorem-foundation-and-esperare-advance</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-announces-plans-collaboration-n-lorem-foundation-and-esperare-advance</guid>
<pubDate>Mon, 12 Jan 2026 05:00:00 GMT</pubDate>
<description>The planned collaboration highlights the role of complete genome resolution in scaling n-of-1 therapeutic models MENLO PARK, Calif., Jan. 12, 2026 (GLOBE</description>
</item>
<item>
<title>PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-uc-davis-researchers-introduce-140500129</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-uc-davis-researchers-introduce-140500129</guid>
<pubDate>Thu, 08 Jan 2026 14:05:00 GMT</pubDate>
<description>Community-developed approach combines multi-contact 3C with HiFi sequencing to deliver haplotype-resolved assemblies from minimal input materialMENLO PARK, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced CiFi, a new community-developed method that enables chromosome-scale, haplotype-resolved genome assemblies from a single sequencing run, even when sample material is limited. By integrating chromatin</description>
</item>
<item>
<title>PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-present-44th-annual-jp-morgan-healthcare-conference-2025-12-30</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-present-44th-annual-jp-morgan-healthcare-conference-2025-12-30</guid>
<pubDate>Tue, 30 Dec 2025 05:00:00 GMT</pubDate>
<description>MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,</description>
</item>
<item>
<title>PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-participate-piper-sandler-37th-annual-healthcare-conference-2025-11-28</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-participate-piper-sandler-37th-annual-healthcare-conference-2025-11-28</guid>
<pubDate>Fri, 28 Nov 2025 05:00:00 GMT</pubDate>
<description>MENLO PARK, Calif., Nov. 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,</description>
</item>
<item>
<title>PacBio to Present at Upcoming Investor Conferences</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-present-upcoming-investor-conferences-2025-11-13</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-present-upcoming-investor-conferences-2025-11-13</guid>
<pubDate>Thu, 13 Nov 2025 05:00:00 GMT</pubDate>
<description>MENLO PARK, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,</description>
</item>
<item>
<title>PacBio Announces Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-announces-third-quarter-2025-financial-results-2025-11-05</link>
<guid isPermaLink="true">https://6ix.com/company/pacific-biosciences-of-california/news/pacbio-announces-third-quarter-2025-financial-results-2025-11-05</guid>
<pubDate>Wed, 05 Nov 2025 05:00:00 GMT</pubDate>
<description>MENLO PARK, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2025. Third</description>
</item>
</channel>
</rss>